Health X Platform Limited strategy deck summary

Strategy deck of 10 Jun 2026, summarised by AI from the filing.

Health X proposes a composite scheme to demerge its finance business into MRL and merge SHBL into Health X.

Key takeaways

1. Scheme Health X proposes a composite scheme to demerge its finance business into MRL and merge SHBL into Health X.
2. Approvals The scheme requires approvals from Stock Exchanges, RBI and NCLT.

Original filing on BSE

Health X Platform Limited Q1 FY27 results

As filed: Revenue ₹447 cr, EBITDA −₹8.4 cr, PAT ₹2.0 cr, EBITDA margin -1.9%.

Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹447 cr). Scored once a year-earlier consolidated quarter exists.

Earlier results and the share price after them

• Q4 FY26: Revenue ₹374 cr, EBITDA −₹25.2 cr, PAT −₹13.0 cr, EBITDA margin -6.7%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹374 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +3.6% in 30 days (Nifty 500: +1.5%).

Past price moves after results do not indicate future moves. Not a recommendation.

Health X Platform Limited earnings call, investor presentation and press release summaries

• Q1 FY27: Earnings call (11 Aug 2026), Results deck (7 Aug 2026)
• Q4 FY26: Earnings call (12 Jun 2026), Results deck (1 Jun 2026)
• Q3 FY26: Earnings call (9 Feb 2026), Results deck (6 Feb 2026), Results deck (6 Feb 2026)
• Q2 FY26: Earnings call (17 Nov 2025), Results deck (13 Nov 2025)
• Q1 FY26: Results deck (16 Aug 2025)
• Q4 FY25: Earnings call (12 Jun 2025), Results deck (2 Jun 2025)
• Other events: Strategy deck (10 Jun 2026)